Erlotinib (Erlocip (150mg)) is a tyrosine kinase inhibitor, prescribed for metastatic non-small cell lung cancer, and pancreatic cancer.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Erlocip (150mg) - Cipla Ltd.
Erlocip (150mg) Tablet
Generic : Erlotinib
₹
8638.24
150mg
30 Tablets
Substitute/Alternative Medication to Erlocip (150mg)
When is Erlocip (150mg) prescribed?
It is prescribed for -